Merck (MRK) Change in Acquisitions & Divestments (2009 - 2025)

Merck has disclosed Change in Acquisitions & Divestments across 17 years of filings, most recently posting $46.0 million for Q4 2025.

• In Q4 2025, Change in Acquisitions & Divestments rose 112.43% year-over-year to $46.0 million; the TTM figure through Mar 2026 stood at $1.2 billion (up 523.47% YoY), while the FY2025 annual figure was $1.7 billion, changed N/A from the prior year.
• Change in Acquisitions & Divestments slipped to $46.0 million in Q4 2025, from $575.0 million in the prior quarter.
• Over the last five years, Change in Acquisitions & Divestments for MRK reached as high as $704.0 million in Q3 2023 and fell as low as -$370.0 million in Q4 2024.
• The 5-year median for Change in Acquisitions & Divestments is $285.0 million (2023), against an average of $267.5 million.
• Annual changes were most pronounced in 2023 — Change in Acquisitions & Divestments jumped 49900.0% — and 2024, when it tumbled 318.93%.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $529.0 million in 2021, then slumped by 97.73% to $12.0 million in 2022, then surged by 1308.33% to $169.0 million in 2023, then plunged by 318.93% to -$370.0 million in 2024, then surged by 112.43% to $46.0 million in 2025.
• According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $46.0 million, $575.0 million, and $601.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.